Future of Pharmacy

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

In an interview with Pharmacy Times, Jon Easter discusses the need for pharmacy to align as a profession to achieve policy and research goals.

President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.

When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.

Sara Roszak recounts the Annual NACDS Foundation Dinner and their role in implementing research at the clinical level.

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.

In a session at NACDS Total Store Expo, experts spoke to the success of value-based care models in the pharmaceutical industry.

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

A federal and state policy expert discusses the announcement from the Centers for Medicare & Medicaid Services on the agreement to lower prices for 10 selected drugs due to the Inflation Reduction Act.

The FDA also granted rare pediatric disease designation for the drug.

Chris Peshek of Discount Drug Mart discusses the importance of community pharmacies and the process of building relationships with patients, and how a profession in the field can be rewarding for those seeking to pursue it.

Customers report that their communication is strong with their pharmacists, but only 51% said their pharmacist was trustworthy.

Tune into this episode of “Public Health Matters” to hear a discussion with Dr. Frank North centered around successful mentorship and advocacy for representation across minority groups in the pharmacy profession.

Tune into this episode of “Public Health Matters” to hear a discussion with Dr. Frank North centered around successful mentorship and advocacy for representation across minority groups in the pharmacy profession.

Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.

Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.

If properly implemented, increasing the pharmacist’s clinical authority could ensure increased access to care for patients and advance the practice of pharmacy.

Innovations are expanding opportunities for care.

The findings showed that pharmacist-led interventions resulted in the greatest systolic blood pressure reductions.

The cause of the outage was deemed to be due to a defect found in a content update for Windows users.

Allison Burns discusses how pharmacists should prepare and educate themselves regarding OTC naloxone, and the steps that can be taken in stores and pharmacies to ensure OTC naloxone is visible and available.

Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.

Panelists identify key public policies that pharmacies would benefit from acting on in 2024.

In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.